Internal Medicine, Medical Oncology · New York, NY
NPI
1194014605
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
160 E 53rd St
New York, NY, 10022
Phone (646) 888-4384
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
301 services
Medicare patients, 2024
88
Average age 74
Drug cost, 2024
$824K
199 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danny N Khalil was code 99214 (office e&m - established), 196 times for 48 patients. In total Danny N Khalil billed 301 services in 10 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 196 | 48 | $86.26 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 55 | 22 | $102.99 | $5,665 |
| 99205 Office E&M - New | Office | 33 | 33 | $162.73 | $5,370 |
By year: 2022 $15K for 167 services; 2023 $22K for 216 services; 2024 $29K for 301 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danny N Khalil prescribed most often to Medicare patients was Tibsovo (Ivosidenib), with 23 prescriptions and refills. In total Danny N Khalil wrote 199 Medicare prescriptions that cost $824K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tibsovo Ivosidenib | 23 | 23 | Under 11 | $765K |
| Ondansetron Hcl Generic | 23 | 23 | 20 | $405 |
| Creon Lipase/Protease/Amylase | 17 | 18 | Under 11 | $35K |
| Pantoprazole Sodium Generic | 15 | 19 | Under 11 | $88.81 |
| Potassium Chloride Generic | 13 | 13 | Under 11 | $203 |
| Oxycodone Hcl Generic | 12 | 12 | Under 11 | $120 |
| Ondansetron Odt Ondansetron | 11 | 11 | Under 11 | $470 |
Brand drugs: - claims; generic drugs: 135 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danny N Khalil $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.